Assessment of current product portfolio against competitors' strategies
The client, a leading global healthcare group, wanted to test alternative strategies and understand potential outcomes for its chronic hepatitis B product portfolio against competing drugs.
Synovate organized and facilitated a 3-day business war-game focusing on the client's chronic hepatitis B product portfolio. Two war-games were run in parallel for the reimbursed and non-reimbursed markets.
Prior to the war-gaming workshop, Synovate developed initial market assumptions and hypotheses to provide an overview on the market and competitive environment. During the workshop, Synovate facilitated the teams to brainstorm on likely outcomes, key advantages of strategies and possible retaliation moves from competitors based on various assumptions, as well as to validate the viability and suitability of its strategy in view of a dynamically changing environment.
The client was able to develop an actionable strategy in response to various moves by its competitors. The business war-game also brought a broad acceptance of an agreed strategy within a company and enhanced the alignment of the employee's goals to the company's goals.